Page 18 - pesta2023_4
P. 18

-pest-POSTEN                       Side 18





                                                                                 NTB-Sak 2025-07-0486: Kjøpt bildet NTB 2025-10-21
























        påvirkningen av probiotika  på barnas vekst og   7.  Bargheet A, et al. Development of Early Life Gut
        risiko for diare. Forhåpentligvis vil ProRIDE   Resistome  and  Mobilome  Across Gestational
        studien føre til mye ny og viktig kunnskap, og   Ages and Microbiota-Modifying  Treatments.
        den har allerede  bidratt til å styrke nasjonalt   EBioMedicine 2023; 92: 104613.
        og internasjonalt samarbeid innen forskning   8.  Esaiassen  E,  et  al.  Bifidobacterium  longum
        på  tarmmikrobiom  hos nyfødte  og spedbarn.     Subspecies  infantis  Bacteremia  in  3  Extremely
                                                     Preterm Infants Receiving Probiotics. Emerg Infect
                                                     Dis 2016; 22: 1664-6.
        Referanser                                 9.  Vatne  A, et  al.  Early  Empirical  Antibiotics  and
         1.  Hype or hope? Nat Rev Microbiol 2019; 17, 717.   Adverse Clinical  Outcomes in infants born very
                                                     preterm:  A population-based  cohort. J Pediatr
         2.  Stewart CJ, et al.  The preterm  gut microbiota:   2023; 253:107-114.
           changes  associated  with  necrotizing enterocolitis
           and infection. Acta Paediatr 2012; 101: 1121-7.  10. Klingenberg C, et  al.  Neonatal  morbidity  and
         3.  Lin HC, et al. Oral probiotics prevent necrotizing   mortality  in  a  Tanzanian  tertiary  care  referral
                                                     hospital. Ann Trop Paediatr 2003; 23: 293-9.
           enterocolitis  in very low birth weight preterm
           infants: a multicenter, randomized, controlled trial.   11. Kuwelker  K, et  al.  Use of probiotics  to  reduce
           Pediatrics 2008; 122: 693–700.            infections  and death and prevent colonization
         4.  Cotten CM, et al. Prolonged duration of initial   with  extended-spectrum  beta-lactamase  (ESBL)-
                                                     producing bacteria  among newborn infants in
           empirical  antibiotic  treatment  is associated  with   Tanzania  (ProRIDE  Trial):  study protocol  for a
           increased  rates  of necrotizing  enterocolitis  and   randomized  controlled  clinical  trial.  Trials  2021;
           death  for  extremely  low  birth  weight  infants.     22: 312
           Pediatrics 2009;123:58-66.              12. Tellevik  MG, et  al.  High Prevalence  of Faecal
         5.  Esaiassen E, et al. Antibiotic exposure in neonates   Carriage  of ESBL-Producing  Enterobacteriaceae
           and early adverse outcomes - a Systematic Review   among Children in Dar es Salaam, Tanzania. PLoS
           and  Meta-Analysis.  J  Antimicrob  Chemotherapy   ONE 2016; 11: e0168024.
           2017; 72:1858-70.
         6.  Esaiassen  E,  et  al.  Effects  of  Probiotic   13. Panigrahi P, et al. A randomized synbiotic trial to
                                                     prevent sepsis among infants in rural India. Nature
           Supplementation  on the  Gut  Microbiota  and   2017; 548: 407-12.
           Antibiotic  Resistome  Development  in Preterm
           Infants. Front Pediatr 2018;6: 347
   13   14   15   16   17   18   19   20   21   22   23